東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

The Post-Transcriptional Regulation ...

Reinke, Emily N.

Linked to FindBook

Google Book

Amazon

博客來

The Post-Transcriptional Regulation of Antioxidant Enzymes.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	The Post-Transcriptional Regulation of Antioxidant Enzymes./
Author:	Reinke, Emily N.
Description:	161 p.
Notes:	Source: Dissertation Abstracts International, Volume: 74-12(E), Section: B.
Contained By:	Dissertation Abstracts International74-12B(E).
Subject:	Biology, Molecular. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3573383
ISBN:	9781303435584

The Post-Transcriptional Regulation of Antioxidant Enzymes.
Reinke, Emily N.

The Post-Transcriptional Regulation of Antioxidant Enzymes. - 161 p.

Source: Dissertation Abstracts International, Volume: 74-12(E), Section: B.

Thesis (Ph.D.)--University of Illinois at Chicago, 2013.

A study was conducted exploring the post-transcriptional regulation of four antioxidant enzymes: glutathione peroxidase 1 (GPx1), manganese superoxide dismutase (MnSOD), glutathione peroxidase 4 (GPx4), and thioredoxin reductase 1 (TrxR1). Glutathione peroxidase activity was analyzed in clinical samples from imatinib-treated patients with chronic myelogenous leukemia (CML), which is characterized by the presence of Bcr-Abl. Studies were also conducted in the following human cell lines: KU812 and MEG-01 (CML), LNCaP (prostate cancer), and GM10832 (immortal B lymphocyte). Breakpoint Cluster Region-Abelson (Bcr- Abl) and Mammalian Target of Rapamycin (mTOR) were pharmacologically inhibited because their expression was expected to inhibit the protein levels of the selected antioxidants. Levels of antioxidant protein and activity were measured in cell lines treated with imatinib or rapamycin, the latter of which inhibits mTOR.

ISBN: 9781303435584Subjects--Topical Terms:

1017719
Biology, Molecular.

The Post-Transcriptional Regulation of Antioxidant Enzymes.
LDR:03834nam a2200313 4500 001 1964087
005 20141010091526.5
008 150210s2013 ||||||||||||||||| ||eng d
020 $a 9781303435584
035 $a (MiAaPQ)AAI3573383
035 $a AAI3573383
040 $a MiAaPQ $c MiAaPQ
100 1 $a Reinke, Emily N. $3 2100472
245 1 4 $a The Post-Transcriptional Regulation of Antioxidant Enzymes.
300 $a 161 p.
500 $a Source: Dissertation Abstracts International, Volume: 74-12(E), Section: B.
500 $a Adviser: Alan Diamond.
502 $a Thesis (Ph.D.)--University of Illinois at Chicago, 2013.
520 $a A study was conducted exploring the post-transcriptional regulation of four antioxidant enzymes: glutathione peroxidase 1 (GPx1), manganese superoxide dismutase (MnSOD), glutathione peroxidase 4 (GPx4), and thioredoxin reductase 1 (TrxR1). Glutathione peroxidase activity was analyzed in clinical samples from imatinib-treated patients with chronic myelogenous leukemia (CML), which is characterized by the presence of Bcr-Abl. Studies were also conducted in the following human cell lines: KU812 and MEG-01 (CML), LNCaP (prostate cancer), and GM10832 (immortal B lymphocyte). Breakpoint Cluster Region-Abelson (Bcr- Abl) and Mammalian Target of Rapamycin (mTOR) were pharmacologically inhibited because their expression was expected to inhibit the protein levels of the selected antioxidants. Levels of antioxidant protein and activity were measured in cell lines treated with imatinib or rapamycin, the latter of which inhibits mTOR.
520 $a Glutathione peroxidase activity was found to increase in 4 of 7 CML patient sample sets, which was recapitulated in the two CML cell lines utilized for this study, in which MnSOD and TrxR1 were also increased in response to imatinib treatment. The increase of these three antioxidant proteins occurred only in CML cell lines. The ectopic expression of Bcr-Abl in the prostate cancer cell line LNCaP significantly decreased GPx1 protein; however, MnSOD and TrxR1 were unaltered. This indicates that GPx1 is potentially inhibited by Bcr-Abl, while MnSOD and TrxR1 could be increased in response to the intracellular effects of imatinib. In imatinib-treated CML cells, GPx1 and MnSOD activity levels increased only marginally in comparison to protein levels. This indicates that GPx1 and MnSOD may be post-translationally modified and that their activity is regulated independently of the post-transcriptional regulation that increased protein levels.
520 $a Treatment of both CML and non-CML cell lines with rapamycin, which inhibits mTOR, significantly increased protein levels for GPx1, GPx4, and TrxR1, suggesting that the posttranscriptional regulation of these proteins is dependent on the control of translation by mTOR and its downstream targets. These are all members of the selenoprotein family, the translation of which is dependent on the recoding of the selenocysteine codon by a selenocysteine insertion sequence (SECIS) found in the 3'-UTR of selenoprotein mRNA. The increase in these antioxidant proteins by mTOR inhibition illustrates a potential route by which selenoprotein translation may be regulated independent of selenium availability. Analysis of the effect of mTOR inhibition on a reporter construct dependent on the GPx1 SECIS element for expression did not reveal a difference in activity in the presence of rapamycin. This suggests that the mTOR-dependent translation of GPx1, GPx4, and TrxR1 may be via translation initiation and/or polypeptide chain elongation.
590 $a School code: 0799.
650 4 $a Biology, Molecular. $3 1017719
650 4 $a Chemistry, Biochemistry. $3 1017722
650 4 $a Health Sciences, Pharmacy. $3 1017737
690 $a 0307
690 $a 0487
690 $a 0572
710 2 $a University of Illinois at Chicago. $b Pathology. $3 2100473
773 0 $t Dissertation Abstracts International $g 74-12B(E).
790 $a 0799
791 $a Ph.D.
792 $a 2013
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3573383